[EN] EXATECAN DERIVATIVES AND ANTIBODY-DRUG CONJUGATES THEREOF<br/>[FR] DÉRIVÉS D'EXATECAN ET CONJUGUÉS ANTICORPS-MÉDICAMENT DE CEUX-CI
申请人:[en]ALX ONCOLOGY INC.
公开号:WO2022236136A1
公开(公告)日:2022-11-10
Disclosed herein, in part, are compounds (I) which are exatecan derivatives with novel chemical linkers that include cathepsin B cleavable moieties, and conjugated to targeting antibodies.